Regenicin, Inc. Deferred Income
Regenicin, Inc. had Deferred Income of $12.53 million as of 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredIncome · last filed 2023-05-15
- 2023-03-31: Deferred Income $12.53M.
- 2022-12-31: Deferred Income $12.14M.
| Period end | Deferred Income |
|---|---|
| 2023-03-31 | $12.53M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $12.14M 10-Q · filed 2023-02-13 |